ProCE Banner Activity

Practical Considerations for Administration of Asparaginase-Based Therapy to Patients With ALL: Hypersensitivity or Intolerance or Inactivation?

Slideset Download
Download this slideset from a live CCO symposium for an expert overview of how to identify and optimally manage hypersensitivity reactions associated with asparaginase-based regimens in the treatment of ALL.

Released: December 09, 2022

Expiration: December 08, 2023

No longer available for credit.

Share

Faculty

Kjeld Schmiegelow

Kjeld Schmiegelow, MD, DMSci

Professor
Department of Pediatric Oncology
Righospitalet University Hospital
Copenhagen, Denmark

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Jazz Pharmaceuticals, Inc.

Faculty Disclosure

Primary Author

Kjeld Schmiegelow, MD, DMSci

Professor
Department of Pediatric Oncology
Righospitalet University Hospital
Copenhagen, Denmark